Source
From SEC EDGAR
149 releases originally issued via SEC EDGAR. The issuing organizations are responsible for their content.
COTY ANNOUNCES FIRST QUARTER FISCAL YEAR 2027 RESULTS
Q1 Profit and EPS Ahead of Guidance; Modest Sales Decline of 1%, with LFL Sales Down 2%
Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2026
•Announced updated clinical data in more than 80 patients from the ongoing PiNACLE pivotal trial in patients with 3L+ R/R LBCL and from the Phase 1/2…
Figma Announces Third Quarter 2026 Financial Results
Q3 revenue grew 43% year-over-year to $391.4 million, $16.4 million above the high-end of prior guidance.
Sunrun Reports Third Quarter 2026 Financial Results
Robust sales growth continued in our direct business
Arcutis Announces Third Quarter 2026 Financial Results and Provides Business Update
SiTime Reports Third Quarter 2026 Financial Results
Q3 Net Revenue Increased 257% to $298.7 Million
Rapid7 Announces Third Quarter 2026 Financial Results
•Annualized recurring revenue (“ARR”) of $820 million
3D Systems Reports Third Quarter 2026 Financial Results
Magnite Reports Third Quarter 2026 Results
Contribution ex-TAC(1) Grows 20% Year-Over-Year
GLOBAL NET LEASE REPORTS THIRD QUARTER 2026 RESULTS
–Closed $535 Million Accretive Modiv Industrial Acquisition and Fully Integrated Acquired Portfolio, Achieving Anticipated G&A Synergies With No…
Tenaya Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
Received Regenerative Medicine Advanced Therapy (RMAT) Designation from U.S. FDA for TN-401 Gene Therapy for PKP2-Associated Arrhythmogenic Right…
Niagen Bioscience, Inc. Reports Third Quarter 2026 Financial Results
Launched Niagen™ Plus Niagen™ Liquid At-Home Injections
BBSI Reports Third Quarter 2026 Financial Results
- Revenues up 5% to $334.1 Million and Gross Billings up 3% to $2.40 Billion -